Ohba K - Search Results

1

High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer.

Miyata Y, Watanabe S, Sagara Y, Mitsunari K, Matsuo T, Ohba K, Sakai H. Miyata Y, et al. Among authors: ohba k. PLoS One. 2013;8(3):e59095. doi: 10.1371/journal.pone.0059095. Epub 2013 Mar 13. PLoS One. 2013. PMID: 23516604 Free PMC article.

2

[Clinical study of sarcomatoid renal cell carcinoma].

Ohba K, Koga S, Nishikido M, Miyata Y, Noguchi M, Kanetake H, Kanda S, Hayashi T, Yamada J. Ohba K, et al. Hinyokika Kiyo. 2003 Mar;49(3):131-3. Hinyokika Kiyo. 2003. PMID: 12728524 Free article. Japanese.

3

Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.

Ohba K, Miyata Y, Koga S, Kanda S, Kanetake H. Ohba K, et al. Urology. 2005 May;65(5):1029-34. doi: 10.1016/j.urology.2004.12.032. Urology. 2005. PMID: 15882758

4

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.

Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H. Ohba K, et al. J Urol. 2005 Aug;174(2):461-5. doi: 10.1097/01.ju.0000165150.46006.92. J Urol. 2005. PMID: 16006865

5

Interstitial expression of heat-shock protein 47 correlates with capillary deposition of complement split product C4d in chronic allograft nephropathy.

Ohba K, Miyata Y, Koga S, Nishikido M, Kanetake H, Nazneen A, Razzaque MS, Taguchi T. Ohba K, et al. Clin Transplant. 2005 Dec;19(6):810-6. doi: 10.1111/j.1399-0012.2005.00426.x. Clin Transplant. 2005. PMID: 16313330

6

Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.

Miyata Y, Kanda S, Ohba K, Nomata K, Hayashida Y, Eguchi J, Hayashi T, Kanetake H. Miyata Y, et al. Among authors: ohba k. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):800-6. doi: 10.1158/1078-0432.CCR-05-1284. Clin Cancer Res. 2006. PMID: 16467091

7

Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tract.

Miyata Y, Ohba K, Kanda S, Nomata K, Eguchi J, Hayashi T, Kanetake H. Miyata Y, et al. Among authors: ohba k. Virchows Arch. 2006 Jun;448(6):822-9. doi: 10.1007/s00428-006-0198-1. Epub 2006 Apr 12. Virchows Arch. 2006. PMID: 16609907

8

Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.

Miyata Y, Kanda S, Ohba K, Nomata K, Eguchi J, Hayashida Y, Kanetake H. Miyata Y, et al. Among authors: ohba k. J Urol. 2006 Jul;176(1):348-53. doi: 10.1016/S0022-5347(06)00520-9. J Urol. 2006. PMID: 16753442

9

Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.

Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H. Miyata Y, et al. Among authors: ohba k. Clin Cancer Res. 2006 Dec 1;12(23):6998-7003. doi: 10.1158/1078-0432.CCR-06-1626. Clin Cancer Res. 2006. PMID: 17145820

10

Clinical significance and predictive value of prostaglandin E2 receptors (EPR) 1 - 4 in patients with renal cell carcinoma.

Ohba K, Miyata Y, Watanabe S, Hayashi T, Kanetake H, Kanda S, Sakai H. Ohba K, et al. Anticancer Res. 2011 Feb;31(2):597-605. Anticancer Res. 2011. PMID: 21378344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters